carbamates and sitagliptin phosphate

carbamates has been researched along with sitagliptin phosphate in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's5 (83.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Huang, Q; Peng, Y; Wang, Y; Zhao, L1
Hanafusa, T; Hotta, N; Ioriya, K; Kageyama, S; Kaku, K; Kawamori, R1
Hirose, T; Kumashiro, N; Mori, Y; Nagasawa, K; Nishimura, A; Okubo, M; Uchino, H; Usui, S; Yamato, A; Yasuda, D1
Bi, Y; Engel, SS; Ji, L; Ji, Q; Jia, W; Lu, J; Mao, A; Mu, Y; Ran, X; Weng, J; Xu, W; Yang, W; Yao, B; Zeng, L; Zhao, B; Zhao, J; Zhou, Z; Zhu, D1
Bachmann, HS; Besser, M; Koester, V; Severing, AL; Stuermer, EK; Terberger, N1

Reviews

1 review(s) available for carbamates and sitagliptin phosphate

ArticleYear
Drugs for type 2 diabetes.
    Treatment guidelines from the Medical Letter, 2008, Volume: 6, Issue:71

    Topics: alpha-Galactosidase; Biguanides; Carbamates; Cyclohexanes; Diabetes Mellitus, Type 2; Drug Combinations; Drug Therapy, Combination; Humans; Hypoglycemic Agents; Insulin; Nateglinide; Phenylalanine; Piperidines; Pyrazines; Sitagliptin Phosphate; Sulfonylurea Compounds; Thiazolidinediones; Triazoles

2008

Trials

2 trial(s) available for carbamates and sitagliptin phosphate

ArticleYear
Efficacy and safety of repaglinide added to sitagliptin in Japanese patients with type 2 diabetes: A randomized 24-week open-label clinical trial.
    Endocrine journal, 2016, Dec-30, Volume: 63, Issue:12

    Topics: Aged; Blood Glucose; Carbamates; Diabetes Mellitus, Type 2; Drug Substitution; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Male; Middle Aged; Piperidines; Postprandial Period; Sitagliptin Phosphate; Treatment Outcome

2016
Efficacy and safety of metformin and sitagliptin based triple antihyperglycemic therapy (STRATEGY): a multicenter, randomized, controlled, non-inferiority clinical trial.
    Science China. Life sciences, 2017, Volume: 60, Issue:3

    Topics: Acarbose; Adult; Blood Glucose; Carbamates; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Gliclazide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Piperidines; Sitagliptin Phosphate; Sulfonylurea Compounds; Treatment Outcome

2017

Other Studies

3 other study(ies) available for carbamates and sitagliptin phosphate

ArticleYear
Effects of dipeptidyl peptidase-4 inhibitors in a type 2 diabetes patient with failure of glucagon-like peptide-1 receptor agonists.
    Journal of diabetes, 2014, Volume: 6, Issue:2

    Topics: Blood Glucose; Carbamates; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Exenatide; Fasting; Female; Glucagon-Like Peptide-1 Receptor; Humans; Hypoglycemic Agents; Insulin Glargine; Insulin, Long-Acting; Metformin; Middle Aged; Peptides; Piperidines; Pyrazines; Receptors, Glucagon; Sitagliptin Phosphate; Treatment Failure; Triazoles; Venoms

2014
Clinical study of repaglinide efficacy and safety in type 2 diabetes mellitus patients with blood glucose levels inadequately controlled by sitagliptin.
    Journal of diabetes investigation, 2016, Volume: 7, Issue:2

    Topics: Adult; Aged; Blood Glucose; Carbamates; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Middle Aged; Piperidines; Sitagliptin Phosphate

2016
Side effects of frequently used oral antidiabetics on wound healing in vitro.
    Naunyn-Schmiedeberg's archives of pharmacology, 2019, Volume: 392, Issue:3

    Topics: Administration, Oral; Apoptosis; Carbamates; Caspases; Cell Line; Endopeptidases; Fibroblasts; Gelatinases; Glyburide; Humans; Hypoglycemic Agents; Keratinocytes; Membrane Proteins; Metformin; Piperidines; Receptors, CXCR4; Serine Endopeptidases; Sitagliptin Phosphate; Wound Healing

2019